Cart
sales@molnova.com
Toralactone 9-O-β-D-glucopyranoside
CAS No. 1011710-89-6
Toralactone 9-O-β-D-glucopyranoside( ——— )
Catalog No. M38239 CAS No. 1011710-89-6
Toralactone-9-O-β-D-glucopyranoside is a phenolic component that can be isolated from Eriocaulon buergerianum.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameToralactone 9-O-β-D-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionToralactone-9-O-β-D-glucopyranoside is a phenolic component that can be isolated from Eriocaulon buergerianum.
-
DescriptionToralactone-9-O-β-D-glucopyranoside is a phenolic component that can be isolated from Eriocaulon buergerianum.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1011710-89-6
-
Formula Weight434.39
-
Molecular FormulaC21H22O10
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fang JJ, et al., Antibacterial phenolic components from Eriocaulon buergerianum. Phytochemistry. 2008 Mar;69(5):1279-86.?
molnova catalog
related products
-
Mirzotamab
Mirzotamab is an IgG1κ antibody targeting CD276/B7-H3 and is the naked antibody to Mirzotamab clezutoclax, consisting of 1320 amino acids.
-
Deacetyl asperulosid...
Ddeacetyl asperulosidic acid methyl ester is a natual product isolated from the herbs of Hedyotis diffusa Willdit can lower the blood glucose level in normal mice.
-
α-Synuclein Binding?...
α-Synuclein 4554W is an inhibitor of α-Synuclein (aSyn) aggregation with associated toxicity. α-Synuclein 4554W consists of GIVNGVKA sequences, previously identified through intracellular library screening. α-Synuclein 4554W reduces fibril formation of aSyn mutants assocaited with Parkinson’s disease.
